117 related articles for article (PubMed ID: 15708914)
1. Is IV infliximab better than IV methylprednisolone for the treatment of patients with RA when methotrexate fails?
Smith MD
Ann Rheum Dis; 2005 Mar; 64(3):512; author reply 512. PubMed ID: 15708914
[No Abstract] [Full Text] [Related]
2. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P
Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
[TBL] [Abstract][Full Text] [Related]
3. A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis.
Westhovens R; Houssiau F; Joly J; Everitt DE; Zhu Y; Sisco D; Van Hartingsveldt B; Mascelli MA; Graham MA; Durez P; Bouman-Thio E
J Rheumatol; 2006 May; 33(5):847-53. PubMed ID: 16583466
[TBL] [Abstract][Full Text] [Related]
4. Increase in methotrexate dose in patients with rheumatoid arthritis who have an inadequate response to infliximab.
Ornetti P; Solau E; Gaudin P; Sibilia J; Berthelot JM; Puechal X; Tavernier C; Maillefert JF;
Ann Rheum Dis; 2005 Sep; 64(9):1379-80. PubMed ID: 16100349
[No Abstract] [Full Text] [Related]
5. [Case report: RAEB in a patient with rheumatoid arthritis treated with methotrexate and infliximab].
D'Alessandro G; Bianco MR; Politis S; Ferrandina C; Rossi G; Altomare E
Reumatismo; 2006; 58(1):59-61. PubMed ID: 16639489
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial.
Fleischmann RM; Cohen SB; Moreland LW; Schiff M; Mease PJ; Smith DB; Keenan G; Kremer JM;
Curr Med Res Opin; 2005 Aug; 21(8):1181-90. PubMed ID: 16083527
[TBL] [Abstract][Full Text] [Related]
7. DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment.
Vander Cruyssen B; Van Looy S; Wyns B; Westhovens R; Durez P; Van den Bosch F; Veys EM; Mielants H; De Clerck L; Peretz A; Malaise M; Verbruggen L; Vastesaeger N; Geldhof A; Boullart L; De Keyser F
Arthritis Res Ther; 2005; 7(5):R1063-71. PubMed ID: 16207323
[TBL] [Abstract][Full Text] [Related]
8. Therapy of patients with rheumatoid arthritis: outcome of infliximab failures switched to etanercept.
Buch MH; Bingham SJ; Bejarano V; Bryer D; White J; Reece R; Quinn M; Emery P
Arthritis Rheum; 2007 Apr; 57(3):448-53. PubMed ID: 17394231
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial.
Emery P; Fleischmann R; Filipowicz-Sosnowska A; Schechtman J; Szczepanski L; Kavanaugh A; Racewicz AJ; van Vollenhoven RF; Li NF; Agarwal S; Hessey EW; Shaw TM;
Arthritis Rheum; 2006 May; 54(5):1390-400. PubMed ID: 16649186
[TBL] [Abstract][Full Text] [Related]
10. Predictors of infusion reactions during infliximab treatment in patients with arthritis.
Kapetanovic MC; Larsson L; Truedsson L; Sturfelt G; Saxne T; Geborek P
Arthritis Res Ther; 2006; 8(4):R131. PubMed ID: 16869978
[TBL] [Abstract][Full Text] [Related]
11. Reactions to infliximab in patients with rheumatoid arthritis.
Sakellariou GT; Chatzigiannis I
J Rheumatol; 2005 Jul; 32(7):1411-2. PubMed ID: 15996088
[No Abstract] [Full Text] [Related]
12. Shortening infusion times for infliximab administration.
Buch MH; Bryer D; Lindsay S; Rees-Evans B; Fairclough A; Emery P
Rheumatology (Oxford); 2006 Apr; 45(4):485-6. PubMed ID: 16352636
[No Abstract] [Full Text] [Related]
13. Timing of DAS28 in infliximab therapy.
Armstrong DJ; Bruce IN
Rheumatology (Oxford); 2005 Sep; 44(9):1203-4; author reply 1204. PubMed ID: 15870143
[No Abstract] [Full Text] [Related]
14. Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Symmons DP; Watson KD; Silman AJ;
Arthritis Rheum; 2006 Jun; 54(6):1786-94. PubMed ID: 16736520
[TBL] [Abstract][Full Text] [Related]
15. How to dose infliximab in rheumatoid arthritis: new data on a serious issue.
van Vollenhoven RF
Ann Rheum Dis; 2009 Aug; 68(8):1237-9. PubMed ID: 19605741
[No Abstract] [Full Text] [Related]
16. Infliximab treatment maintains employability in patients with early rheumatoid arthritis.
Smolen JS; Han C; van der Heijde D; Emery P; Bathon JM; Keystone E; Kalden JR; Schiff M; Bala M; Baker D; Han J; Maini RN; St Clair EW
Arthritis Rheum; 2006 Mar; 54(3):716-22. PubMed ID: 16508932
[TBL] [Abstract][Full Text] [Related]
17. [Rituximab (MabThera) as treatment of active rheumatoid arthritis].
El Fassi D; Nielsen CH; Bendtzen K
Ugeskr Laeger; 2006 Nov; 168(47):4079-81. PubMed ID: 17134602
[TBL] [Abstract][Full Text] [Related]
18. Anti-infliximab antibodies in patients with rheumatoid arthritis who require higher doses of infliximab to achieve or maintain a clinical response.
Haraoui B; Cameron L; Ouellet M; White B
J Rheumatol; 2006 Jan; 33(1):31-6. PubMed ID: 16395747
[TBL] [Abstract][Full Text] [Related]
19. Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-tumour necrosis factor alpha.
Conti F; Ceccarelli F; Priori R; Iagnocco A; Signore A; Valesini G
Ann Rheum Dis; 2008 Dec; 67(12):1787-90. PubMed ID: 19005158
[No Abstract] [Full Text] [Related]
20. Dose intensification with infliximab in patients with rheumatoid arthritis.
Berger A; Edelsberg J; Li TT; Maclean JR; Oster G
Ann Pharmacother; 2005 Dec; 39(12):2021-5. PubMed ID: 16288073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]